Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Beissbarth

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Journal of Cancer Research and Clinical Oncology|March 15, 2023
An overview and a roadmap for artificial intelligence in hematology and oncologyWiebke Rösler, Michael Altenbuchinger, Bettina Baeßler, et al.
Gastroenterology|October 9, 2012
Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kitPenelope Pelczar, Arne Zibat, Willemijn A van Dop, et al.
Cancer Cell|April 12, 2017
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaSebastian Mohr, Carmen Doebele, Federico Comoglio, et al.
Gut|December 31, 2025
GSK3β<sup>high</sup>/NFATc1<sup>high</sup> subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repairMuhammad Umair Latif, Xuean Liu, Aiko Bockelmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 2, 2017
Biomarkers predict outcome in Charcot-Marie-Tooth disease 1ARobert Fledrich, Manoj Mannil, Andreas Leha, et al.
Experimental & Molecular Medicine|March 3, 2018
Whither systems medicine?Rolf Apweiler, Tim Beissbarth, Michael R Berthold, et al.
Neuromuscular Disorders : NMD|August 3, 2014
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patientsManoj Mannil, Alessandra Solari, Andreas Leha, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Journal of Cancer Research and Clinical Oncology|March 15, 2023
An overview and a roadmap for artificial intelligence in hematology and oncologyWiebke Rösler, Michael Altenbuchinger, Bettina Baeßler, et al.
Gastroenterology|October 9, 2012
Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kitPenelope Pelczar, Arne Zibat, Willemijn A van Dop, et al.
Cancer Cell|April 12, 2017
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaSebastian Mohr, Carmen Doebele, Federico Comoglio, et al.
Gut|December 31, 2025
GSK3β<sup>high</sup>/NFATc1<sup>high</sup> subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repairMuhammad Umair Latif, Xuean Liu, Aiko Bockelmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 2, 2017
Biomarkers predict outcome in Charcot-Marie-Tooth disease 1ARobert Fledrich, Manoj Mannil, Andreas Leha, et al.
Experimental & Molecular Medicine|March 3, 2018
Whither systems medicine?Rolf Apweiler, Tim Beissbarth, Michael R Berthold, et al.
Neuromuscular Disorders : NMD|August 3, 2014
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patientsManoj Mannil, Alessandra Solari, Andreas Leha, et al.
Pageof 13